Abacavir and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Abacavir (abacavir sulfate), especially for people who are male, 40-49 old, also take Etravirine, and have Hepatitis c.

The phase IV clinical study analyzes which people have Uveitis when taking Abacavir. It is created by eHealthMe based on reports of 8,281 people who have side effects when taking Abacavir from the FDA, and is updated regularly.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,529 conditions by eHealthMe. Check the latest studies of Uveitis.

On Jul, 15, 2026

8,281 people reported to have side effects when taking Abacavir.
Among them, 27 people (0.33%) have Uveitis.

Among these 27 people:

What is the gender of people who have Uveitis when taking Abacavir? *

female: 3.85 %
male: 96.15 %

What is the age of people who have Uveitis when taking Abacavir? *

What are other drugs people take besides Abacavir? *

Etravirine: 18 people, 66.67%
Sovaldi: 13 people, 48.15%
Rebetol: 8 people, 29.63%
Sofosbuvir: 7 people, 25.93%
Stavudine: 3 people, 11.11%
Norvir: 3 people, 11.11%
Lamivudine: 3 people, 11.11%
Zidovudine: 2 people, 7.41%
Loratadine: 2 people, 7.41%
Clindamycin Hydrochloride: 2 people, 7.41%

What are other side effects people have besides Uveitis? *

Visual Acuity Reduced (reduced clearness of vision): 13 people, 48.15%
Disease Progression: 7 people, 25.93%
Blindness: 4 people, 14.81%
Weakness: 3 people, 11.11%
Drug Ineffective: 3 people, 11.11%
Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 3 people, 11.11%
Haemolytic Anaemia (anaemia due to haemolysis): 2 people, 7.41%
Headache (pain in head): 2 people, 7.41%
Dizziness: 2 people, 7.41%
Nausea (feeling of having an urge to vomit): 2 people, 7.41%

What are the existing conditions these people have? *

Pyoderma (any skin disease that is pyogenic): 1 person, 3.70%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 3.70%
High Blood Pressure: 1 person, 3.70%
Hepatitis C: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Abacavir and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abacavir:

Abacavir (8,306 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,529 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Abacavir) and Abacavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.